Radiation therapy‐associated toxicity: Etiology, management, and prevention
K Wang, JE Tepper - CA: a cancer journal for clinicians, 2021 - Wiley Online Library
Radiation therapy (RT) is a curative treatment for many malignancies and provides effective
palliation in patients with tumor‐related symptoms. However, the biophysical effects of RT …
palliation in patients with tumor‐related symptoms. However, the biophysical effects of RT …
Management of glioblastoma: State of the art and future directions
Glioblastoma is the most common malignant primary brain tumor. Overall, the prognosis for
patients with this disease is poor, with a median survival of< 2 years. There is a slight …
patients with this disease is poor, with a median survival of< 2 years. There is a slight …
Radiation therapy for brain metastases: an ASTRO clinical practice guideline
Purpose This guideline provides updated evidence-based recommendations addressing
recent developments in the management of patients with brain metastases, including …
recent developments in the management of patients with brain metastases, including …
Single-and multifraction stereotactic radiosurgery dose/volume tolerances of the brain
Purpose As part of the American Association of Physicists in Medicine Working Group on
Stereotactic Body Radiotherapy investigating normal tissue complication probability (NTCP) …
Stereotactic Body Radiotherapy investigating normal tissue complication probability (NTCP) …
Current standards of care in glioblastoma therapy
C Fernandes, A Costa, L Osório, RC Lago… - Exon …, 2017 - exonpublications.com
Glioblastoma (GBM) is the most common primary malignant brain tumor in adults.
Regardless of ideal multidisciplinary treatment, including maximal surgical resection …
Regardless of ideal multidisciplinary treatment, including maximal surgical resection …
ESTRO-ACROP guideline “target delineation of glioblastomas”
M Niyazi, M Brada, AJ Chalmers, SE Combs… - Radiotherapy and …, 2016 - Elsevier
Background and purpose Target delineation in glioblastoma (GBM) varies substantially
between different institutions and several consensus statements are available. This …
between different institutions and several consensus statements are available. This …
Clinical evidence of variable proton biological effectiveness in pediatric patients treated for ependymoma
CR Peeler, D Mirkovic, U Titt, P Blanchard… - Radiotherapy and …, 2016 - Elsevier
Background and purpose A constant relative biological effectiveness (RBE) is used for
clinical proton therapy; however, experimental evidence indicates that RBE can vary. We …
clinical proton therapy; however, experimental evidence indicates that RBE can vary. We …
UK 2022 consensus on normal tissue dose-volume constraints for oligometastatic, primary lung and hepatocellular carcinoma stereotactic ablative radiotherapy
P Diez, GG Hanna, KL Aitken, N Van As, A Carver… - Clinical Oncology, 2022 - Elsevier
The use of stereotactic ablative radiotherapy (SABR) in the UK has expanded over the past
decade, in part as the result of several UK clinical trials and a recent NHS England …
decade, in part as the result of several UK clinical trials and a recent NHS England …
Long-term risk of radionecrosis and imaging changes after stereotactic radiosurgery for brain metastases
Radionecrosis is a well-characterized effect of stereotactic radiosurgery (SRS) and is
occasionally associated with serious neurologic sequelae. Here, we investigated the …
occasionally associated with serious neurologic sequelae. Here, we investigated the …
Radiation therapy for glioblastoma: executive summary of an American Society for Radiation Oncology evidence-based clinical practice guideline
Purpose To present evidence-based guidelines for radiation therapy in treating glioblastoma
not arising from the brainstem. Methods and materials The American Society for Radiation …
not arising from the brainstem. Methods and materials The American Society for Radiation …